Although details of the trial and the efficacy of the drug treatment are still unknown, the study is still good news for the potential it may bring to scientists’ further understanding of anti-Mag and other forms of autoimmune neuropathy.
The Foundation for Peripheral Neuropathy is working to further scientific knowledge on anti-Mag as well through the IMAGiNe study, announced last year.
If you would like to be kept apprised of future developments on the IMAGiNe study, or other studies related to anti-MAG peripheral neuropathy, contact us at [email protected].
Healthy fats improve nerve function in mice
More evidence that diet plays an integral part in nerve health.
Researchers at Indiana University School of Medicine have developed a prototype for a blood test that can objectively measure pain. The objective measure of pain can lead to better diagnoses and better treatments.
A study by researchers in Texas shed even more light on the cellular origins of chronic pain, giving indications on which part of the brain treatments should focus to bring relief.
The Foundation for Peripheral Neuropathy hosted a webinar on the affect that new tax regulations may have on charitable giving, in the U.S. and how donors can continue to contribute to meaningful causes in tax-friendly ways. Speakers included Lou Mazawey, President of the Foundation for Peripheral Neuropathy and Principal, Groom Law, Mark Friese, Senior Vice President-Wealth Management for Menick, Friese, Phillips Bock Group/Merrill Lynch &Co, and Daniel H. Ruttenberg, Attorney and Counsellor at Law, SmolenPlevy.
Mark Friese has provided additional information on charitable planned giving and some planned giving structures that allow you to make an impact with your gift and receive potential tax benefits as well. You can find this information here.
Please contact Lindsay at [email protected] or 847-883-9942 if you have any questions for FPN or for our expert webinar panel.
The Foundation for Peripheral Neuropathy provides education and support today as we walk toward a cure for tomorrow.
Support us in advancing a cure!
FPN is a non-profit organization that is solely funded by our readers.